Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

3 treatments under study, led by Ganciclovir

Related Conditions

Often studied with 5 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

100%

2 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

2Total
Phase 3 (1)
Phase 4 (1)

Trial Status

Completed2

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 2 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT00707941Phase 3Completed

Oseltamivir Randomised Controlled Efficacy Trial

NCT01533480Phase 4Completed

A Placebo Controlled Comparison of Topical Zirgan Versus Genteal Gel for the Treatment of Adenovirus Conjunctivitis

Showing all 2 trials

Research Network

Common Treatments

  • Ganciclovir1
  • Hypromellose1
  • Oseltamivir1

Active Sponsors

  • International Centre for Diarrhoeal Disease Research, Bangladesh1
  • Lifelong Vision Foundation1
  • Centers for Disease Control and Prevention1
  • Bausch & Lomb Incorporated1

Top Investigators

Related Conditions

  • Pneumonia1
  • Upper Respiratory Tract Infection1
  • Lower Respiratory Tract Infection1
  • Keratoconjunctivitis Due To Adenovirus1
  • Influenza1

Activity Timeline